Constellation Pharmaceuticals
About Constellation Pharmaceuticals
In July 2021, MorphoSys acquired Constellation Pharmaceuticals. This transformational acquisition bolstered MorphoSys' position as a leader in hematology and oncology and marked the beginning of an important next chapter in the company's history.
MorphoSys' mission is to give more life for people with cancer. As a global commercial-stage biopharmaceutical company, MorphoSys uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. MorphoSys is headquartered in Planegg, Germany, and has its U.S. operations anchored in Boston, Massachusetts.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of Constellation Pharmaceuticals
Here you will find Constellation Pharmaceuticals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.